Document resource
Background/Objectives Approximately 10% of sporadic 70% of familial MND patients carry an underlying pathogenic cause for their MND. Promising trials and treatment opportunities rely on early genotype identification, and with Medicare rebates now available, neurologists can order genomic testing directly. Due to its complexity and widespread impact, genomic testing should be offered with genetic counselling (GC) support.In order to provide timely and accessible genetic counselling we propose a 12–18 month Pilot Project providing community-based, on-call genetic counselling support with three main aims:Provide Victorian and Tasmanian MND families with thorough, equitable genetic counselling support regarding genomic testing.Improve routine MND care, by educating and supporting MND treating teams to integrate genomics into their practice.Development of best practice guidelines genomics in MND care.Methods (in development of project) Liaison with MND Victoria, and MND physicians to determine the community’s need for genetic counselling support and information.Creation of online resources regarding genomic test implications, consent, and testing instructions for clinicians and families.Thorough evaluation of the effectiveness and acceptability of this pilot project.Results Development of a community-based GC Pilot Program, in collaboration with MND Victoria.Increased access to essential genetic counselling for both MND families, and MND professionals.Contribution towards MND genomic care guidelines and acceptability of this pilot project.Conclusion The provision of genetic counselling support both for families with MND and treating professionals will improve the availability of prompt, equitable and safe genomic testing across Victoria and Tasmania in the future.